Nishant C. Saxena
Chief Business Officer · Corbus Pharmaceuticals Holdings, Inc.
- 2026
- Aug 12, 2026
- 3
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Nishant C. Saxena files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Yuval Cohen - $751K in CRBP purchases and sales in the last 12 months
- Sean F. Moran - $378K in CRBP purchases and sales in the last 12 months
- Dominic Smethurst - $77K in CRBP purchases and sales in the last 12 months
- Anne Altmeyer - $41K in CRBP purchases and sales in the last 12 months
- John Kenneth Jenkins - $38K in CRBP purchases and sales in the last 12 months
- Ian Hodgson - $26K in CRBP purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Nishant C. Saxena?
Nishant C. Saxena is a corporate insider, tracked as Chief Business Officer of Corbus Pharmaceuticals Holdings, Inc. (CRBP). InsiderAlpha holds 3 primary Form 4 filings for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Nishant C. Saxena submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has Nishant C. Saxena been buying or selling stock?
Recorded transactions: 3 open-market purchases ($126K) and 0 open-market sales across all tracked filings.
